Bishal Gyawali, Associate Professor at Queen’s University, shared on LinkedIn:
“In this important new Open Access paper in ESMO Open led by Antonio Lázaro Sánchez and Javier David Benitez fuentes and other BG Lab colleagues Laure-Anne Teuwen and Elen Baloyan, in collaboration with Drs. Winette van der Graaf and Denis Lacombe, from EORTC, we discuss why access to clinical trials is an important equity metric but also how ‘not all clinical trials are created equal.”
Just like when we argue for access to cancer drugs, it means access to meaningful drugs not just any drugs. Similarly, when we argue for access to clinical trials, it does not mean access to any trials but to meaningful patient centric trials.”
Title: Access to cancer clinical trials in Europe: when trial availability does not match patient need
Authors: A.D. Lázaro Sánchez, J.D. Benitez-Fuentes, L.-A. Teuwen, E. Baloyan, J.L. Alonso Romero, A. Rodriguez-Lescure, D. Lacombe, W.T.A. van der Graaf, B. Gyawali
Read the Full Article on ESMO Open
Other posts featuring Bishal Gyawali on OncoDaily.
